Clinical Trial: "A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Major Depressive Disorder
Study Type: INTERVENTIONAL
Official Title: A Phase III, Placebo-Controlled, Randomized, Double-Blind Trial of Oral Doses of CYB003 to Assess Combined Safety and Efficacy in Humans With Major Depressive Disorder
Brief Summary:
The purpose of this study is to examine the efficacy, safety, and tolerability of CYB003 compared to matching placebo as adjunctive treatment in participants with MDD.
Read more